Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation

Annals of Hematology

Volumn 74, Issue 1, 1997, Pages 1-6

  Jiang, Y Z ^a   Barrett, A J ^a   Goldman, J M ^a   Mavroudis, D A ^b  

^a Hematology Branch   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bone marrow transplantation (BMT); CD4 cells; CD8 cells; Chronic myeloid leukemia (CML); Graft vs host disease (GVHD); Graft vs leukemia (GVL); Immune recovery; NK cells

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CD16 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAUNORUBICIN; INTERLEUKIN 2; LYMPHOCYTE ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CD4-CD8 RATIO; FEMALE; GRAFT VS HOST DISEASE; GRAFT VS HOST REACTION; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031015677     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050246     Document Type: Article

References (27)

1. Horowitz MM, Gale RP, Sondel PM, et al (1990) Graft versus leukemia reactions after bone marrow transplantation. Blood 75:555-562
2. Cullis JO, Jiang YZ, Schwarer AP, Hughes TP, Barrett AJ, Goldman JM (1992) Donor leukocyte infusion in the treatment of chronic myeloid leukemia in relapse following allogeneic bone marrow transplantation (letter). Blood 79:1379-1381
3. Martin PJ, Hansen JA, Buckner CD (1985) Effects of in vitro depletion of T-cells in HLA-identical allogeneic marrow graft. Blood 66:664-675
4. Truitt RL, Atasoylu AA (1991) Contribution of CD4 + and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow. Bone Marrow Transplant 8:51-58
5. Faber LM, van Luxmberg-Heijs R, Willemze R, Falkenberg JHF (1992) Generation of cytoloxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. J Exp Med 176:1283-1288
6. Glass B, Uharek L, Gassmann W, Focks B, et al (1992) Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease. Ann Hematol 64:255-259
7. Przepiorka D, Parkman R (1995) Graft-versus-host disease and the graft-versus-leukemia effect: report of a workshop. Bone Marrow Transplant 15:5124-127
8. Lowdell MW, Craston R, Prentice HG (1995) NK cell-mediated specific anti-leukemia activity after autologous bone marrow transplantation for acute leukemia (abstract). Blood 86 [Suppl 1]:459a
9. Herberman RB, Reynolds CW, Ortaldo JR (1986) Mechanism of cytotoxocity by natural killer cells. Annu Rev Immunol 4:651-680
10. Gidlund M, Om A, Pattengal PK, Jansson M, Wigzell H, Nilsson K (1981) Natural killer cells kill tumor cells at a given stage of differentiation. Nature 292:848-850
11. Nakano E, Tada Y, Ichikawa Y, et al (1987) Lysis of autologous tumor cells by peripheral blood lymphocytes treated with interleukin 2 in patients with renal cell carcinoma. J Urol 137:641-647
12. Adler A, Chervenick PA, Whiteside TL, et al (1988) Interleukin 2 induction of LAK activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission. Blood 71:709-716
13. Hercend T, Takvorian T , Nowill A, et al (1986) Characterization of natural killer cells with anti-leukemia activity following allogeneic bone marrow transplantation. Blood 76:722-728
14. Keever CA, Klein J, Leong N, Copelan EA, Avalos BR, Kapoor N, Cunningham I, Tutschka PJ (1993) Effect of GVHD on the recovery of NK cell activity and LAK precursors following BMT. Bone Marrow Transplant 12:289-295
15. Mackinnon S, Hows JM, Goldman JM (1990) Induction of in vitro graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemia. Blood 76:2037-2045
16. Niederwieser D, Gastl G, Rumpold H, Marth Ch, Kraft D, Huber H (1987) Rapid reappearance of large granular lymphocytes with concomitant reconstitution of natural killer activity after human bone marrow transplantation. Br J Haematol 65:301-305
17. Jiang YZ, Kanfer EJ, MacDonald D, Cullis JO, Goldman JM, Barrett AJ (1991) Graft versus leukemia effect following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes to host leukemia cells. Bone Marrow Transplant 8:253-258
18. Hoffmann T, Theobald M, Bunjes D, Weiss M, Heimpel H, Heit W (1993) Frequency of bone marrow T cells responding to HLA-identical non-leukemic and leukemic stimulator cells. Bone Marrow Transplant 12:1-8
19. Jiang YZ, Cullis JO, Kanfer EJ, Goldman JM, Barrett AJ (1993) T cell and NK cell-mediated graft versus leukemia reactivity following donor buffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 11:133-138
20. Bunjes D, Theobald M, Hertenstein B, Wiesneth M, Novotny J, Arnold R, Heimpel H (1995) Successful therapy with donor buffy coat transfusions in patients with relapsed CML after BMT is associated with high frequencies of host-reactive IL-2-secreting T helper cells. Bone Marrow Transplant 15:713-719
21. Kurago ZB, Smith KD, Lutz CT (1995) NK cell recognition of MHC class I: NK cells are sensitive to peptide-binding groove and surface α-helical mutations that affect T cells. J Immunol 154:2631
22. Malnati MS, Peruzzi M, Parker KC, et al (1995) Peptide specifity in the recognition of MHC class I by natural killer cell clones. Science 267:1016-1018
23. Jiang YZ, Couriel D, Mavroudis DA, Lewalle P, Malkovska V, Hensel NF, Dermime S, Molldrem J, Barrett AJ (1996) Interaction of NK cells with MHC class II: reversal of HLA-DR1-mediated protection of K562 transfectant from NK cell-mediated cytolysis by brefeldin-A. Immunology 87:481-486
24. Delain M, Tiberghien P, Racadot E, et al (1994) Variability of the alloreactivity T-cell response to human leukemia blasts. Leukemia 8:642-647
25. Matulonis UA, Dosiou C, Lamont C et al (1995) Role of B7-1 in mediating an immune response to myeloid leukemia cells. Blood 85:2507-2515
26. Munker RL Lubbert M, Yonehara S, Tuhnitz A, Mertelsmann R, Wilmanns W (1995) Expression of the fas antigen on primary human leukemia cells. Ann Hematol 70:15-22
27. Antin JH, Ferrara JLM (1992) Cytokine dysregulation and acute graft-versus-host disease. Blood 80:2964-2970